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Abstract 
 Changes in the composition of gut microbiota are implicated in the pathogenesis of several 
neurodegenerative disorders. Here, we investigated whether gut bacteria affect the hallmarks of 
Huntington’s disease (HD) in transgenic Drosophila melanogaster (fruit fly) models expressing 
human full-length or N-terminal fragments of mutant huntingtin (HTT) protein, here referred to 
as HD flies. We find that elimination of commensal gut bacteria by antibiotics reduces the 
aggregation of amyloidogenic N-terminal fragments of HTT and delays the development of 
motor defects. Conversely, colonization of HD flies with Escherichia coli (E. coli), a known 
pathobiont of human gut, accelerates HTT aggregation, aggravates immobility and shortens life 
span. Similar to antibiotics, treatment of HD flies with compounds such as luteolin, a flavone, or 
crocin a beta-carotenoid, ameliorates disease phenotypes and promotes survival. Crocin prevents 
colonization of E. coli in the HD flies gut and alters the levels of commensal bacteria, which may 
be linked to its protective effects. The opposing effects of E. coli and crocin on HTT 
aggregation, motor defects and survival in transgenic Drosophila support the involvement of gut-
brain networks in the pathogenesis of HD.  
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1. Introduction 
Huntington’s disease (HD) is a progressive genetically inherited neurodegenerative disorder 
characterized by debilitating motor, psychiatric, and cognitive symptoms (Bates et al., 2015, 
Ghosh and Tabrizi, 2018). Expansion of a CAG repeat (>35) in the exon 1 of huntingtin (HTT) 
gene, which translates into an abnormal polyglutamine (polyQ) tract, is the underlying cause of 
HD (Huntington’s Disease Collaborative Research Group, 1993). The expanded polyQ enhances 
the amyloidogenic properties of HTT exon1 (HTTex1) peptide, which misfolds and forms 
insoluble protein assemblies in neurons (Difiglia, et al., 1997). Expansion of polyQ repeat is a 
major determinant of disease onset, however, multiple genetic and environmental factors may 
affect the progression of HD. One potential modifier is neuroinflammation exemplified by 
elevated levels of inflammatory microglia and TH17.1 cells in the brains of pre-manifest HD 
patients. The increase in the activated immune cells coincides with the abnormal production of 
inflammatory cytokines, which persists during the symptomatic stages of HD (Björkqvist, et al., 
2008, Politis, et al., 2015, Von Essen, et al., 2020). Although mutant HTT has directly been 
implicated in the activation of inflammatory pathways, the environmental inducers of 
inflammation in HD remain to be investigated (Khoshnan, et al., 2004, Trager et al., 2014, 
Khoshnan et al., 2017).   
Commensal and acquired gut microorganisms are prominent sources of inflammogens 
implicated in neurological disorders. Within the last decade, extensive studies demonstrate that 
the gastrointestinal (GI) tract and its resident microbes (collectively known as microbiota, and 
their genomes as microbiome) regulate the nervous system physiology. For example, gut 
microbiota influences neurodevelopment, neurodegeneration, neurotrophin and neurotransmitter 
production, neuropsychiatric and motor behaviors, and neuroinflammation (Sharon and 
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Mazmanian, 2016, Sampson et al., 2016, Morais, et al., 2021). Changes in the homeostasis of gut 
microbiota (dysbiosis) have been linked to the pathogenesis of several neurological and 
neurodegenerative disorders, including, autism spectrum disorder (ASD), multiple sclerosis 
(MS), Alzheimer's disease (AD), Parkinson's disease (PD) and amyotrophic lateral sclerosis 
(ALS) (Hsiao et al., 2013, Sampson, et al., 2016, Marizzoni et al., 2020, Takewaki, et al., 2020, 
Zeng et al., 2020). Neuroinflammation is a prominent feature of gut dysbiosis in 
neurodegenerative disorders, which includes the activation of microglia and subsequent 
production of inflammatory cytokines (Sampson et al., 2016, Abdel-Haq, et al., 2018). Notably, 
inflammatory bacteria such as Enterobacteriaceae are elevated in the gut microbiota of PD 
patients and their abundance correlates with the worsening of the neurological and pathological 
symptoms (Keshavarzian et al., 2015, Scheperjans, et al., 2015, Li et al., 2017). Moreover, 
lipopolysaccharides (LPS), major components of gram negative bacteria, which include 
Enterobacteriaceae, have been implicated in the pathogenesis of PD (Perez-Pardo, et al., 2019). 
Gut dysbiosis manifested by reduced alpha diversity in the bacterial communities were recently 
reported in a cohort of HD patients. Notably, in these studies changes in the abundance of 
Eubacterium halii coincide with altered cognition (Wasser et al., 2020). Another gut microbiome 
analysis  of a group of HDs patient’s links blooming of gram-negative bacteria Bilophila species 
to elevated levels of inflammatory cytokines (Du et al., 2021). In transgenic mouse models of 
HD expressing the neurotoxic mutant HTTex1 peptide, gut dysbiosis has been linked to weight 
loss, motor deficit, metabolic changes and disruption in the intestinal epithelium (Kong et al., 
2020, Stan et al., 2020, Kong et al., 2021). These promising studies highlight a potential role of 
gut microbiota in the pathogenesis of HD. However, the mechanism of how a specific bacterium 
may affect disease manifestation remains to be investigated.  
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Drosophila (fruit fly) is emerging as a useful model to study the impact of gut-brain 
interactions on the phenotypes of neurodegenerative disorders (Douglas AE, 2018). Similar to 
mammals, gut homeostasis in Drosophila is regulated by the interaction of bacteria with the 
enteric neurons and intestinal epithelium including the enteroendocrine cells, which produce 
antimicrobial peptides (AMPs) involved in immunity against invasive pathogens and maintaining 
optimal abundance of commensal bacteria (Hanson and Lemaitre, 2020). Drosophila has only a 
handful of commensal gut bacteria, which can easily be manipulated for studies on gut-brain 
communications (Douglas AE, 2018, Ankrah, et al., 2021). Lactobacillus and Acetobacter 
species are the two most abundant bacterial genera, which regulate nutrients acquisition, growth, 
metabolism, immune development and locomotion (Schretter, et al., 2018, Storelli, et al., 2018, 
Henriques, et al., 2020, Yamauchi, et al., 2020, Ankrah, et al., 20201). The Drosophila models of 
HD display several hallmarks of disease progression including protein aggregation, motor 
defects, and aberrant gene expression including those implicated in inflammation (Barbaro, et al., 
2015, Al-Ramahi, et al., 2018). The simplicity of Drosophila gut microbiota offers a useful 
platform to rapidly examine the influence of endogenous and single exogenous gut bacterial 
species on HD progression and to investigate the role of HTT in gut–brain pathways. As a first 
step, we explored whether elimination of gut bacteria in HD Drosophila models or colonization 
with human pathobiont E. coli influences disease development. Here, we report that gut bacteria 
promote the aggregation of amyloidogenic N-terminal fragments of HTT, contribute to 
development of aberrant motor behavior and reduce the life span of HD flies. We further provide 
evidence that editing the gut environment of HD flies with therapeutic agents ameliorates disease 
and promotes survival. 
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2. Materials and methods 
2.1. Fly stocks  
The huntingtin expressing transgenic Drosophila lines used in this study were M{UAS-   
HTT.ex1.Q25}, M{UAS-HTT.ex1.Q120}, M{UAS-HTT.FL.Q25}, M{UAS-hHTT.fl.Q120}and 
M{UAS-HTT.586.Q120} (Barbaro et al., 2015, Chongtham et al., 2020). The GAL4 drivers 
used in the experiments were the pan-neuronal elav-Gal4 C155 driver (Bloomington Stock 
Number B#458) and ubiquitous da-Gal4 (B#8641). Fly cultures were maintained on standard 
cornmeal/sugar/agar media on a 12:12 hour light:dark cycle. Appropriate crosses were carried 
out to obtain desired progenies. Briefly, standard food vials with 10 males and 10 females of 
appropriate genotype were allowed to mate for 2 days and then passed into new vials at 20°C. 
All assays used female progeny, which were collected after the eclosion and maintained at 20°C 
for 2-3 days until enough flies had been collected.  
2.2. Treatment of flies with antibiotics or small molecules 
For drug treatment, groups of 15-20 female flies were placed in vials containing standard 
cornmeal/sugar/agar food alone for non-treatment control experiments or standard food mixed 
with 1mg/ml of water-soluble test compounds crocin (cat# 17304 Sigma), rifaximin (cat# 
Y0001074, Sigma), luteolin (# L9283 Sigma) or 1% penicillin-streptomycin (cat#15140-122; 
Gibco). The flies were transferred to 25°C and passaged to fresh vials every second or third day. 
For treatment with live bacteria, curli producing (MC4100) and curli deficient (Δcsg) E. coli 
strains from -80°C frozen stocks were grown on YESCA (1% Casamino Acids, 0.12% yeast 
extract, 2% Bacto agar) agar plates at 25°C for 48 hr. Lactobacillus rhamnosus strain (JB-1, 
ATCC) from frozen stock was streaked on MRS (ingredient) agar plates and grown at 37°C 
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overnight. Acetobacter stock was prepared by grinding adult flies in PBS followed by culturing 
of isolated bacteria in mannitol agar plate. Isolated colonies were grown in liquid manitol broth 
at 37°C in bacterial shaker. The bacterial cultures were harvested by centrifugation (3000xg, 
5min), washed and resuspended in PBS. The bacterial suspension (0.5 OD or 5x107 cells) was 
then mixed with standard food and groups of 15-20 female progeny which had been first treated 
with 1% penicillin-streptomycin- supplemented food for 3 to 4 days, were transferred to the 
bacteria supplemented food. The flies were transferred to new food with the live bacteria every 
second or third day at 25°C. 
To examine the effects of crocin on E. coli treated flies, crocin (1mg/mL) and E.coli 
(0.5OD or 5x107 cells) were both mixed with standard food and flies, which had been treated 
with 1% penicillin-streptomycin for 3-4 days, were transferred to the crocin and E. coli mixed 
food. Flies were transferred to fresh food every second or third day and their bacterial load and 
motor behavior was monitored.  
2.3. Western blotting 
At least 10 wandering third instar larvae or adult flies were lysed and homogenized in RIPA 
buffer (25mM Tris-HCl pH7.6, 150mM NaCl, 1% NP-40, 1mM EDTA) with protease inhibitors 
(Complete, Mini Protease Inhibitor Cocktail, Roche Applied Science). The lysates were then 
boiled at 95°C for 5 min, and equal amount of proteins were separated by SDS/PAGE on pre-
cast 4-20% polyacrylamide gradient gels (Cat# 5671094, Biorad) and transferred to immune-blot 
PVDF membrane (Merck cat# IPVH00010). Membranes were blocked with blocking solution 
(5% non-fat milk in 0.05% Tween in PBS) and incubated with primary anti-HTT antibody PHP1 
(1:1000 in blocking solution) overnight at 4°C. The blots were then treated with HRP-conjugated 
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goat anti-moue secondary antibody (1:10000) diluted in blocking solution for 1 h and developed 
with enhanced chemiluminescent (ECL) substrate (Cat#1705060, Biorad). 
2.4. SDD-AGE 
To separate SDS-resistant amyloid assemblies, semi-denaturing detergent agarose gel 
electrophoresis (SDD-AGE) was performed (Halfman and Lindquist, 2008) with some 
modifications. Fly lysates were prepared as described above and resolved by electrophoresis in 
SDD-AGE gels (1.5% agarose, 1X TAE, 0.1% SDS). Proteins were transferred to immune-blot 
PVDF membrane by overnight downward capillary action using 1X TBS. Membranes were then 
treated as western blots above. 
2.5. Immunostaining of larval brains and guts of adult flies 
Wandering third instar larvae were cut into anterior and posterior halves, and the anterior halves 
were turned inside out and placed in PBS on ice. These halves were then fixed by rocking for 30 
min at RT with 4 % formaldehyde made in PBST (PBS + 0.2 % Triton X-100). After fixation, 
halves were washed three times with PBT, blocked with 5 % BSA in PBT for 1 hr at RT, probed 
overnight with primary antibody (s) at 4°C, washed, blocked again and incubated with secondary 
antibody (s) for 2 h and washed again. Larval brains were then dissected out and mounted in 
Vectashield-DAPI medium. The primary antibodies were rat-Elav-7E8A10 anti-elav (used at 
1:200 dilution in PBS; Developmental Studies Hybridoma Bank), PHP1 anti-HTT (used at 1:500 
dilution in PBS; Ko et al., 2018). The secondary antibodies were Alexa Fluor 488 goat anti-
mouse (green) and Alexa Fluor 568 goat anti-rat (red) (used at 1:250 dilution in blocking 
solution, Life Technologies). 
Whole guts of adult flies were dissected out in PBS, fixed in 4% formaldehyde in PBT 
for 1 h, washed with PBT and incubated with blocking buffer for 1h at RT. The guts were then 
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probed with anti-E. coli monoclonal antibody (produced in house) overnight at 4°C. After 
washing with PBST, guts were incubated with Alexa Fluor 488 goat anti-mouse antibody diluted 
in blocking buffer for 2 hr at RT and washed. The guts were mounted in Vectashield-DAPI 
medium. Images of mounted tissues were captured using a Leica Sp8 laser scanning microscope 
and analyzed using Leica Application Suite X (LAS X) software. 
2.6. Climbing Assay 
For monitoring the locomotor ability, 10 flies were gently tapped to the bottom of a vertical glass 
vial (diameter, 2.2 cm)., as adapted from Liu et al., 2008. The number of flies that climbed a 
height of 5 cm within 10 s was recorded. The test was repeated three times each for 4 vials of 
10 flies at 1 min intervals. 
2.7. Longevity assay 
A longevity assay was performed as described previously with slight modifications (Barbaro et 
al., 2015). Briefly, eighty eclosed female flies (1-3 days old) were divided into 4 tubes of twenty 
each with the indicated treatment in the figure legends were maintained at 20℃ with a 12:12 hr 
light:dark cycle. Longevity assays in the presence of E.coli were performed at 25℃ to 
accommodate  bacterial growth.  Progenies were and transferred to fresh vials with standard food 
+/- treatment. Cultures were monitored every other day and the number of dead flies counted.  
2.8. Congo Red staining of bacterial colonies and CFU counting 
To determine the E. coli (Curli-producing) load in the gut, flies were surface sterilized with 70% 
ethanol for 1 min and washed three times with sterile 1X PBS. Flies were then homogenized in 
groups of 5 in 500 μL of sterile 1X PBS using a motorized pestle. Microbial counts were 
determined by serial dilution plating of the homogenates on YESCA agar plates supplemented 
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with 50 µg/mL of Congo Red (CR) (Sigma). The YESCA CR plates were incubated at 25°C for 
2 days to induce curli production and the number of red colonies that showed curli expression 
were counted. 
2. 9. Quantification of dead pupae 
Four groups of 10 each UAS-HTTex1-120Q males and elav-Gal4 female virgins were allowed to 
mate for 2 days at 20℃ and passaged daily into vials with standard food supplemented with 
crocin (1mg/mL) or 1% penicillin-streptomycin for a span of 4 days. Twenty days after crosses 
were made, all flies were emptied from the vials, and empty pupal cases and cases containing 
dead flies were counted to calculate the percentage of pupal survival (Hatfield et al., 2015). 
2.10. 16S sequencing of gut bacteria 
Flies were harvested on the indicated days post-eclosion, gently disinfected in 70% ethanol and 3 
subsequent rinse in PBS to remove any external bacteria and stored immediately at  
-80°C. Similar samples for different batches of flies were mixed and shipped to sequencing 
facility at Zymo Research Irvine, CA. Briefly, bacterial DNA was extracted using 
ZymoBIOMICS-96 MagBead DNA kit (Zymo Research Irvine, CA). The DNA samples were 
prepared for targeted sequencing with the Quick-16S NGS library Prep kit and 16S primer set 
V3-V4 (Zymo Research Irvine, CA). The final library was sequenced on Ilumina MiSeq with a 
V3 reagent Kit (600 cycles). The sequencing was performed with 10% PhiX Spike-in. 
2.11. Bioinformatics Analysis of bacteria   
Unique amplicon sequences were inferred from raw reads using the Dada2 pipeline (Callahan et 
al., 2016). Chimeric sequences were also removed with the Dada2 pipeline. Taxonomy 
assignment was performed using Uclust from Qiime v.1.9.1. Taxonomy was assigned with the 
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Zymo Research Database, a 16S database that is internally designed and curated, as reference. 
Composition visualization, alpha-diversity, and beta-diversity analyses were performed with 
Qiime v.1.9.1 (Caporaso et al., 2010). If applicable, taxonomy that have significant abundance 
among different groups were identified by LEfSe (Segata et al., 2011) using default settings. 
Other analyses such as heatmaps, Taxa2SV_deomposer, and PCoA plots were performed with 
internal scripts. 
2.12. Absolute Abundance Quantification 
A quantitative real-time PCR was set up with a standard curve. The standard curve was made 
with plasmid DNA containing one copy of the 16S gene and one copy of the fungal ITS2 region 
prepared in 10-fold serial dilutions. The primers used were the same as those used in Targeted 
Library Preparation. The equation generated by the plasmid DNA standard curve was used to 
calculate the number of gene copies in the reaction for each sample. The PCR input volume (2 
μl) was used to calculate the number of gene copies per microliter in each DNA sample. The 
number of genome copies per microliter DNA sample was calculated by dividing the gene copy 
number by an assumed number of gene copies per genome. The value used for 16S copies per 
genome is 4. The value used for ITS copies per genome is 200. The amount of DNA per 
microliter DNA sample was calculated using an assumed genome size of 4.64 x 106 bp, the 
genome size of Escherichia coli, for 16S samples, or an assumed genome size of 1.20 x 107 bp, 
the genome size of Saccharomyces cerevisiae, for ITS samples. This calculation is shown below: 
Calculated Total DNA = Calculated Total Genome Copies × Assumed Genome Size (4.64 × 106 
bp) × Average Molecular Weight of a DNA bp (660 g/mole/bp) ÷ Avogadro’s Number (6.022 x 
1023/mole). 
2.13. Statistical analysis 
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Error bars show Standard Error of the Mean (SEM = standard deviation/square root of n). 
Statistical significance was established using analysis of variance (ANOVA) with Tukey’s post 
hoc test on Prism software (GraphPad) (*=P<.05, **=P<.01, ***=P<.001). 
3. Results 
3.1. Gut Bacteria promote the aggregation of N-terminal fragments of HTT in Drosophila  
Recent studies implicate gut bacteria in the aggregation of amyloidogenic proteins such as α-
synuclein (Sampson et al., 2020). The mutant HTTex1 misfolds and aggregates when expressed 
in animal models and produces neurotoxic assemblies (Barbaro et al., 2015, Bates et al., 2015). 
We used transgenic Drosophila (fruit fly) expressing HTTex1 (120Qs) (Ex1-HD line) under the 
control of pan-neuronal driver elav-Gal4 to study to impact of gut bacteria on aggregation. We 
generated larvae in the presence of a gut-specific antibiotic rifaximin and examined for the 
accumulation of HTTex1 assemblies by Western blots (WBs) and immunohistochemistry (IHC). 
Rifaximin inhibits the growth of dominant commensal gut bacteria Lactobacilli and Acetobacter 
species in HD flies, which can be monitored by cultivation on agar plates (Supplementary fig. 
1A). Rifaximin treatment significantly reduces the levels of HTTex1 aggregates in the nervous 
system of Ex1-HD larvae (Fig. 1A and B). Given that HTTex1 is selectively expressed in 
neurons, these findings suggest that the gut bacteria may alter neuronal pathways, which may 
regulate the proteostasis of HTTex1. We then asked whether human gut bacteria with links to  
neurodegeneration may have a similar effect. Escherichia coli (E. coli) a gut pathobiont, has 
been implicated in the pathogenesis of PD. In particular, gut colonization of transgenic human α-
synuclein mice or normal rats with an E. coli strain expressing the functional bacterial amyloids 
curli accelerates the aggregation of α-synuclein in the brain (Chen et al., 2016, Sampson et al., 
2020). We used an HD fly line ubiquitously expressing the N-terminal 586 AA fragment of 
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mutant HTT (120Qs) (N-586 HD) to explore the impact of E. coli on aggregation. HTT 
aggregation in this line is much slower than the Ex1-HD line thus, making it ideal for testing 
agents, which may accelerate this hallmark of HD (Barbaro et al., 2015). We produced the N-586 
HD larvae on food containing an E. coli strain expressing curli or an isogenic mutant where the 
operon for curli has been deleted (Reichhardt et al., 2015). We find that colonization with either 
strain accelerates the aggregation of N-586 HTT fragment (Fig. 1C). While we do not observe 
any selective effects of curli on HTT proteostasis in the N-586 HD flies, recombinant curli 
promotes the aggregation of mutant HTTex1-EGFP when co-expressed in HEK-293 tissue 
culture cells (Supplementary fig. 2A-C). A likely explanation is that curli may need direct 
interaction with mutant HTT to induce misfolding, whereas other aggregation-promoting 
components of E. coli common to both strains may function indirectly. Collectively, these 
findings identify gut bacteria as modifiers of HTT aggregation in fly models of HD. We also 
explored whether E. coli may induce protein aggregation in transgenic flies ubiquitously 
expressing full-length mutant HTT (120Qs) (FL-HD flies). Using various aggregate-specific 
antibodies (Ko et al., 2018, Chongtham et al., under review), we did not detect any HTT 
aggregates in flies treated with or without E. coli (Supplementary fig. 3). However, we cannot 
rule out the formation of unstable oligomers or assemblies, which may not bind to antibodies 
used in these studies. 
3.2. Gut Bacteria contribute to motor defects and death of HD flies 
Abnormal motor behavior is a cardinal symptom of HD. Gut bacteria have been implicated in the 
locomotion of Drosophila (Shretter et al., 2018). Given that E. coli promotes HTT aggregation, 
we asked whether it may alter the motor behavior of HD flies. The N-586 HD flies do not 
develop mutant HTT-mediated motor defects, however, colonization with E. coli significantly 
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impairs their climbing ability. Colonization with Lactobacillus rhamnosus (JB-1 strain) (L. 
rhamnosus), a gram-positive human probiotic has no effects (Fig. 1D). Moreover, E. coli does 
not alter the mobility of flies expressing WT HTT (Supplementary fig. 4A) suggesting that it 
may induce the toxicity of N-586 HTT fragment, which manifests as motor defects in the 
transgenic flies. E. coli also promotes the mortality of the N-586 HD flies; by day 20 ~ 50% of 
the flies die and the rest remain immobile and expire within few days (Fig. 1E). Curli-producing 
E. coli appears more toxic than the isogenic mutant strain indicating that curli may affect the 
mortality of N586-HD flies independent of HTT aggregation and locomotive defects (Fig. 1E).  
Flies expressing full-length mutant HTT (FL-HD) develop progressive motor defects 
when compared to those expressing normal HTT (25Qs) (Fig. 2A). To examine the role of gut 
bacteria on the mobility of FL-HD, we treated ~3 days old adult flies with rifaximin or 
penicillin-streptomycin (PS) and evaluated their climbing ability at different intervals. Treatment 
with either rifaximin or PS ameliorates the motor defects of FL-HD flies (Figs. 2A, 4A). 
Conversely, colonization of FL-HD flies with E. coli exacerbates the climbing defects but has no 
effects on flies expressing full-length WT HTT (Fig. 2B, Supplementary fig. 4A). Colonization 
with L. rhamnosus does not alter the mobility of FL-HD flies or those expressing FL-WT HTT 
(Fig. 2B, Supplementary fig. 4B). Notably, feeding excess Acetobacter senegalensis (A. 
senegalensis), a commensal gram-negative bacterium of Drosophila also accelerates the motor 
defects of FL-HD flies (Fig. 2B). The similar debilitating climbing defects induced by two E. 
coli strains and A. senegalensis are consistent with a pathogenic role of gram-negative bacteria in 
the motor behavior of HD flies. E. coli colonization also significantly reduces the survival of FL-
HD flies and similar to the N-586 HD model, the curli-producing strain appears more pathogenic 
(Fig. 2C). Immunostaining of the gut of E. coli-fed HD flies (FL-HD or the N-586 HD) shows 
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the accumulation of E. coli in the midgut (Fig. 2D, Supplementary fig. 5), which contains 
enterocytes and enteric neurons regulating host-microorganism interactions (Dutta, et al., 2015, 
Capo et al., 2019). The localized accumulation of E. coli in the midgut is noteworthy as it 
confirms spatial colonization and a niche, which may participate in gut-brain communications.  
3.3. Crocin ameliorates HD phenotypes in Drosophila models 
Gut-based regulation of mutant HTT neurotoxicity is a potential therapeutic target. Given that 
rifaximin treatment of Ex1-HD flies reduces the accumulation of neurotoxic HTTex1 assemblies 
in neurons, we examined whether gut-based natural compounds might have a similar effect. We 
focused on anti-inflammatory compounds since inflammation occurs early in pre-manifest HD 
patients and is recognized as a modifier of HD pathogenesis (Politis et al., 2015). Moreover, 
inflammation is a prominent outcome of dysbiosis linked to neurodegeneration (Sampson et al., 
2016, Goyal et al., 2021). Therefore, we generated Ex1-HD larvae on foods containing luteolin, a 
flavone which we have found to inhibit the IKKβ-dependent aggregation of HTTex1 in human 
neurons (Khoshnan et al., 2017), or crocin, a carotenoid abundant in the medicinal plant Crocus 
sativus (saffron) and known for its anti-inflammatory properties and inhibiting the aggregation of 
amyloidogenic proteins like α-synuclein (Inoue et al., 2018, Shafiee et al., 2018). We find that 
similar to antibiotics (rifaximin or penicillin-streptomycin) treatment with luteolin or crocin 
reduces the aggregation of HTTex1 in the nervous system of Ex1-HD larvae (Figs. 1A and B, 3A 
and B, Supplementary fig. 6). Crocin or antibiotics also enhance the eclosion efficiency of Ex1-
HD flies (Fig. 3C) further reinforcing the gut-mediated modulation of HTTex1 aggregation and 
toxicity. 
Interestingly, addition of crocin, rifaximin or luteolin to fly food ameliorates the motor 
defects of FL-HD flies with crocin being the most potent compound (Fig. 4A). Crocin also 
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improves the severe motor defects of FL-HD flies colonized with E. coli (Fig. 4B). In survival 
assays, crocin extends the life span of FL-HD flies and those treated with E. coli +/- curli (Fig. 
4C and D, respectively). Mechanistically, we find that crocin treatment blocks the colonization 
and accumulation E. coli in the flies’ gut (Fig. 4E, supplementary fig. 7). Crocin does not inhibit 
the growth of E. coli in culture thus, its inhibitory effects on gut colonization may be due to the 
induction of flies’ anti-microbial defense pathways. The similar protective effects of crocin and 
antibiotics in two HD fly models suggest that crocin may alter the abundance and/or physiology 
of gut microbiota.  
3.4. Crocin modulates the composition of gut bacteria in flies  
To determine whether crocin changes the composition of gut bacteria in HD flies, we performed 
16S rRNA sequencing. Our Drosophila stocks including those with human HTT transgenes 
predominantly harbor several Lactobacilli strains and Acetobacter senegalensis (A. senegalensis) 
species. Notably, Lactobacilli and Acetobacter show temporal fluctuation in abundance, which 
may be related to flies’ physiology and nutritional demand (Schretter, et al., 2018, Storelli, et al., 
2018, Henriques, et al., 2020, Yamauchi, et al., 2020, Ankrah, et al., 2021) (Fig. 5). Flies 
expressing HTT transgenes (WT or mutant) differ with respect to the relative abundance of 
Lactobacilli and A. senegalensis when compared to control flies (Da-Gal4) (Fig. 5 A-C). 
Interestingly, FL-HD flies harbor elevated levels of A. senegalensis and changes in the 
abundance of various Lactobacilli species when compared to flies expressing WT HTT (Fig. 
5C). Whether these changes alter the metabolic homeostasis of HD flies and contribute to disease 
progression remain to be determined. Notably, elevation of Acetobacter has been linked to 
induced mortality in Drosophila (Obata et al., 2018). Indeed, HD flies fed excess A. senegalensis 
develop severe motor defects, which is similar in magnitude to those produced by E. coli (Fig. 
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2B). Crocin treatment alters the abundance of Acteotbacter and Lactobacillus in all tested fly 
lines independent of HTT transgene expression (Fig. 5D-F). Notably, crocin reduces the elevated 
levels of A. senegalensis but increases the abundance of Lactobacillus-NA (not annotated in data  
bank) in 5-day old FL-HD flies, however, the effects do not persist (Fig. 5F). Whether these 
early changes contribute to the protective effects of crocin in the HD flies remain to be 
investigated. We predict that crocin may alter the signaling pathways, which regulate the 
homeostasis of Lactobacilli and A. senegalensis species based on the flies’ nutrients demand 
(Storelli, et al., 2018, Yamauchi, et al., 2020). Such systemic metabolic changes may translate 
into protection observed in the crocin-treated HD flies.  
4. Discussion 
Recent studies in HD patients and mouse models support a potential role for gut microbiota in 
disease progression (Kong et al., 2020, Wasser et al., 2020, Du et al., 2021, Kong et al., 2021). 
However, how a single commensal or opportunistic gut bacterium may influence the 
pathogenesis of HD remains a challenging area of research considering the complexity of gut 
microbiota and redundancy in functions attributed by various commensal microorganisms in 
mammals. Here we attempted to uncover the role of gut bacteria in the development of HD in 
Drosophila. We provide evidence that gut bacteria promote mutant HTT aggregation, induce 
aberrant locomotive behavior and reduce the survival of transgenic HD flies. More specifically, 
we have identified Acetobacter, a commensal fly bacterium, and E. coli a human pathobiont, as 
gut modifiers of HD pathogenesis. As a proof of concept, we have further demonstrated that 
editing the gut environment of HD flies by a gut-specific antibiotic rifaximin, which is approved 
to treat dysbiosis in Hepatic Encephalopathy patients (Bureau et al., 20201), or small 
nutraceuticals such as luteolin or crocin delays disease progression. These studies are a prelude 
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to further mechanistic investigations of microbiota-brain interactions in HD and the discovery of 
gut-based therapies. 
Our results indicate that elimination of gut bacteria by antibiotics in the Ex1-HD flies 
significantly reduces the aggregation of amyloidogenic N-terminal HTTex1. The findings are 
further reinforced by the induction of mutant HTT aggregation by two strains of E. coli in the N-
586 HD flies. Recent studies indicate that several gram-negative bacteria promote the 
aggregation of polyQ peptides and impair the motility of nematode C. elegans by disrupting 
proteostasis in neurons, muscle and intestinal cells (Walker et al., 2021). Our studies are 
consistent with these findings and underscore the importance of gut bacteria in promoting the 
misfolding and aggregation of amyloidogenic HTT fragments. Surprisingly, several bacterial 
species have been detected in the brain tissues of HD patients. Abundant among them are 
members of Enterobacteriaceae family, which include E. coli and other gram-negative bacteria 
(Alonso et al., 2019). How bacteria gain access to the brains of HD patients and whether they 
affect the proteostasis of HTT remain unknown. Our results however, indicate that bacteria such 
as E. coli may signal the aggregation of HTT from the gut. Notably, antibiotic treatments of Ex1-
HD flies reduce the aggregation of HTTex1 selectively expressed in neurons (Figs. 1A and B, 
3A and B) thus, supporting a role for the gut microbiota on misfolding and aggregation of 
amyloidogenic HTT fragments in the nervous system. Enterobacteriaceae blooming in the gut 
also positively correlates with motor impairment in PD patients (Scheperjans et al., 2015). 
Moreover, E. coli expressing the functional amyloids curli in the gut has been identified as a 
promoter of α-synuclein aggregation in the brains of rodents, which coincides with accelerated 
motor defects (Chen et al., 2016, Sampson et al., 2020). Our data did not show a selective impact 
of curli-producing E. coli on HTT aggregation and the locomotive defects of HD flies but curli 
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had a negative effect on life span and promoted HTTex1 aggregation in mammalian tissue 
culture (Figs. 1 and 2, Supplementary fig 2). These findings suggest curli may need close contact 
with HTT to promote its aggregation and is potentially unable to enter Drosophila cells. 
Moreover, the negative effects of curli on the survival of HD flies may be independent of HTT 
aggregation. Notably, E. coli and A. senegalensis (a fly commensal) produced similar debilitating 
effects on locomotion in HD flies, which is consistent with gram-negative bacteria being 
modifiers of HD symptoms. A recent study highlighted a negative correlation between the 
abundance of gram-negative Bilophila species and the aberrant inflammatory cytokine response 
in HD patients (Du et al., 2021). Our findings along with studies on the microbiota of HD 
patients support the potential involvement of specific classes of gut bacteria in promoting HD  
development (Wasser et al., 2020, Du et al., 2021). Given the abundance of inflammogen LPS in 
the outer membranes of gram-negative bacteria, and the hypersensitivity of immune cells of HD 
patients to LPS (Trager et al., 2014), it will be interesting to investigate whether LPS-mediated 
disruptions in gut-brain networks contribute to the pathogenesis of  HD. 
 The ability to modify HD pathology from the gut is therapeutically useful and attractive. 
Our data indicate that inclusion of crocin in the diet suppresses HTT aggregation, ameliorates 
locomotive defects and increases the survival of HD flies including those colonized with E. coli. 
The effects of crocin on the composition of gut bacteria in Drosophila was difficult to dissect 
due to few commensal species. However, crocin treatment altered the abundance of 
Lactobacillus and Acetobacter in the young FL-HD flies (Fig. 5F), and prevented colonization of 
E. coli in the gut (Fig. 4E, Supplementary fig. 7). In rodents, crocin modifies gut microbiota and 
prevents neurodegeneration in cerebral ischemia models (Zhang et al., 2019), and mitigates 
glucocorticoids-induced dysbiosis in mice by increasing the alpha diversity of gut bacteria and 
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subsequent normalization of aberrant lipid metabolism (Xie et al., 2019). Crocin and its major 
byproduct crocetin do not penetrate the gut epithelium in mammals suggesting that its protective 
effects are induced by modification of gut physiology and/or its microbiota (Zhang et al., 2019, 
Xie et al., 2019). Given that alpha diversity of gut bacteria is decreased in HD patients and in HD 
mice (Kong et al., 2020, Stan et al., 2020, Wasser et al., 2020, Du et al., 2021), the application of 
crocin as a promoter of bacterial diversity in HD models with complex microbiota may provide 
useful knowledge on specific species, which regulate HD progression. In addition to identifying 
gut biomarkers, such studies may also produce novel therapeutic targets for HD. The anti-
oxidative stress properties of crocin are also noteworthy and may contribute to its therapeutic 
effects observed in our studies (Cerda-Bernad et al., 2020). Oxidative stress disrupts numerous 
signaling pathways in HD, which may include inflammatory circuits and genes identified in 
transgenic HD fly models (Kumar and Ratan, 2016, Al-Ramahi et al., 2018, Onur et al., 2021).   
 In summary, our data support a link between gut bacteria and HD pathogenesis in 
transgenic Drosophila models and highlight the involvement of gram-negative bacteria in 
regulating the toxicity of mutant HTT. The neurotoxic phenotypes induced by E. coli in HD fly 
models including motor defects and mortality, are useful biomarkers to investigate the gut-brain 
circuits at a cellular and molecular level. The Drosophila GI tract shares anatomical and 
functional similarities to mammalian equivalent (Apidianakis and Rahme, 2011). The midgut 
where E. coli colonizes (Figs. 2 and 4) is enriched in numerous cell types including the 
enteroendocrine (EE) cells, which perform similar tasks as in human GI cells and are nodes for 
gut-brain networks implicated in neurodegeneration (Chandra et al., 2017). Future knowledge on 
the transcriptome and proteomics of EE cells exposed to E. coli in the context of WT and mutant 
HTT may identify some of the earliest events, which may trigger the neurotoxicity of mutant 
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprintthis version posted August 13, 2021. ; https://doi.org/10.1101/2021.08.12.456124doi: bioRxiv preprint 
HTT in the nervous system. The inclusion of crocin as an inhibitory agent of E. coli toxicity in 
HD fly models may also identify overlapping pathways, potentially functioning in the opposite 
directions, or compensatory circuits beneficial to HD. Crocin has a long history of medicinal use 
and has produced favorable outcomes in CNS disorders including AD, PD, ischemia, mood 
disorders and LPS-induced cognitive decline (Rejaei et al., 2016, Zhang et al., 2018, Haeri et al., 
2019, Zhang et al., 2019, Azmand and Rajaei, 2021). The therapeutic benefits of crocin in 
subjects with depression have been attributed to the induction of neurortophins expression 
including brain-derived neurotropic factor (BDNF) (Ghasemi et al., 2015, Moghadam et al., 
2021, Wu et al., 2017). This property of crocin may prove useful for HD considering the role of 
HTT in BDNF expression and transport; biological activities which are diminished in neurons 
expressing mutant HTT (Zuccato, Cattaneo, 2014). These features and the gut-modifying 
properties of crocin make it or its derivatives attractive therapeutic candidates for HD. 
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Figure 1. Microbiota modulate HTT aggregation, locomotor behavior and lifespan of 
Drosophila HD models. (A) Western blot detection of mutant HTTex1 aggregates in the lysates 
of untreated or rifaximin-treated Ex1-HD larvae, using anti-HTT (PHP1) antibody. Each lane 
represents larvae isolated from a different fly vial. (B) Representative confocal images of brains 
from the Ex1-HD larvae treated with rifaximin and immunolabelled with anti-HTT (PHP1, 
green). DAPI (blue) was used to stain the nuclei. (C) SDD-AGE and WB analysis of lysates (50 
μg each) derived from the N-586 HD flies untreated (C), or colonized with E. coli or E. coli 
expressing curli. PHP1 antibody was used to detect HTT aggregates. (D) N-586 HD flies were 
fed curli-producing/deficient E. coli or L. rhamnosus. A climbing assay was performed at day 20 
after eclosion as described in M&M. (E) The percentage of flies surviving at day 20 was 
calculated and plotted for each experimental condition.  
Figure 2. Gut bacteria regulate the motor function and lifespan of  FL-HD Drosophila. (A) 
Newly eclosed FL-HD flies or controls expressing full length HTT with 25Qs (WT-HTT) were 
treated with  penicillin-streptomycin (PS) for 15 days to eliminate gut bacteria. A climbing assay 
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was performed at days 1, 5, 10 and 15 post-treatment. (B) Bacteria-deficient adult FL-HD flies 
were fed different strains of E. coli, A. senegalensis, L. rhamnosus for 15 days. Locomotive 
behavior for each condition was quantified as in part A. Part C shows the survival curve for FL-
HD flies treated with two E. coli strains. The percent of flies that survived over time was 
calculated at different time points (D). Immunostaining of the GI tract of control or E. coli (curli) 
treated FL-HD flies demonstrating bacterial colonization of fly gut. A monoclonal antibody 
generated to  E. coli  was used for detection. DAPI was used to stain the nuclei.  
Figure 3. Crocin and antibiotics reduce HTTex1 aggregation and mortality. (A) SDD-AGE 
and WB analysis of lysates generated from the Ex1-HD larvae treated with crocin or 
penicillin/streptomycin (PS). PHP1 antibody was used to detect aggregates. Elav-Gal4 larvae 
were used as a negative control. (B) Confocal images of brains from Ex1-HD larvae untreated 
(control) and treated with crocin and PS, and immunolabelled with PHP1 (green), anti-Elav 
antibody (red) and DAPI (blue). Part C shows the percent of pupal survival of Ex1-HD larvae 
treated  with crocin or PS.  
Figure 4. Crocin ameliorates E. coli-induced motor defects and mortality in FL-HD flies. 
(A) Freshly eclosed FL-HD flies were treated with rifaximin, luteolin and crocin for 15 days and 
their climbing ability was evaluated. (B) Climbing assay was performed to monitor the motor 
function of flies colonized with crocin, E. coli or E. coli plus crocin. Untreated FL-HD flies were 
used as control. Part C and D show the percentage of FL-HD flies, which survived over time 
(days) under different treatments. Temperature was elevated to 25 ℃ to accommodate E. coli 
growth. (E) Representative confocal images of the GI tract of untreated (control) FL-HD flies or 
those treated with E. coli (curli) or E. coli plus crocin for 15 days showing bacterial colonization 
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and suppression by crocin treatment. Immunostaining was performed using a monoclonal 
antibody reactive to E. coli. DAPI was used to stain the nuclei.  
Fig. 5.  Relative abundance of Lactobacilli strains and A. senegalensis in the gut of HD flies 
by 16S rRNA gene sequence analysis. (A) Comparative analysis of DA-Gal4 flies with those 
expressing WT-HTT, (B) DA-Gal4 with FL-HD flies and (C) WT-HTT with FL-HD. Parts D-F 
show the effects of crocin on the abundance of bacteria in DA-Gal4, WT-HTT and FL-HD flies, 
respectively. All analyses were performed as described in the materials and methods by 
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